These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 34180245

  • 1. Intensive Lifestyle Intervention Increases Plasma Midregional Proatrial Natriuretic Peptide Concentrations in Overweight Children.
    Thomsen CF, Goharian TS, Larsen KT, Goetze JP, Andersen LB, Jeppesen JL.
    J Am Heart Assoc; 2021 Jul 06; 10(13):e020676. PubMed ID: 34180245
    [Abstract] [Full Text] [Related]

  • 2. Plasma proatrial natriuretic peptide associates with lipid oxidation during exercise and cardiorespiratory fitness in healthy young adults.
    Thomsen CF, Ried-Larsen M, Goetze JP, Andersen LB, Faber J, Grøntved A, Jeppesen JL.
    Peptides; 2019 Dec 06; 122():170156. PubMed ID: 31550524
    [Abstract] [Full Text] [Related]

  • 3. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S, Hansen TW, Goetze JP, Rossing P.
    Am J Hypertens; 2015 Jun 06; 28(6):772-9. PubMed ID: 25468806
    [Abstract] [Full Text] [Related]

  • 4. Serum proatrial natriuretic peptide concentrations during oral glucose-induced acute hyperinsulinemia in lean and obese men.
    Asferg CL, Nielsen SJ, Andersen UB, Linneberg A, Goetze JP, Jeppesen JL.
    Peptides; 2019 Jan 06; 111():98-102. PubMed ID: 29524563
    [Abstract] [Full Text] [Related]

  • 5. Associations of Proatrial Natriuretic Peptide with Components of the Metabolic Syndrome in Adolescents and Young Adults from the General Population.
    Goharian TS, Goetze JP, Faber J, Andersen LB, Grøntved A, Jeppesen JL.
    Am J Hypertens; 2017 Jun 01; 30(6):561-568. PubMed ID: 28338810
    [Abstract] [Full Text] [Related]

  • 6. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.
    Fischer M, Katan M, Morgenthaler NG, Seiler M, Müller B, Lackner P, Errath M, Helbok R, Pfausler B, Beer R, Schmutzhard E, Broessner G.
    Cerebrovasc Dis; 2014 Jun 01; 37(2):128-33. PubMed ID: 24481415
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of a one-year multi-component day-camp intervention for overweight children: study protocol of the Odense overweight intervention study (OOIS).
    Larsen KT, Huang T, Møller NC, Andersen LB, Ried-Larsen M.
    BMC Public Health; 2014 Apr 05; 14():313. PubMed ID: 24708676
    [Abstract] [Full Text] [Related]

  • 8. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL.
    J Am Coll Cardiol; 2008 May 13; 51(19):1857-64. PubMed ID: 18466800
    [Abstract] [Full Text] [Related]

  • 9. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia.
    Masiá M, Papassotiriou J, Morgenthaler NG, Hernández I, Shum C, Gutiérrez F.
    Clin Chem; 2007 Dec 13; 53(12):2193-201. PubMed ID: 17951293
    [Abstract] [Full Text] [Related]

  • 10. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 11. Mid-regional pro-atrial natriuretic peptide and blood pressure in adolescents: effect of gender and pubertal stage.
    Goharian TS, Gimsing AN, Goetze JP, Faber J, Andersen LB, Grøntved A, Jeppesen JL.
    Blood Press; 2015 Nov 13; 24(6):347-52. PubMed ID: 25968593
    [Abstract] [Full Text] [Related]

  • 12. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD.
    Bernasconi M, Tamm M, Bingisser R, Miedinger D, Leuppi J, Müller B, Christ-Crain M, Stolz D.
    Chest; 2011 Jul 13; 140(1):91-99. PubMed ID: 21106656
    [Abstract] [Full Text] [Related]

  • 13. Relation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension.
    Khaleghi M, Al-Omari MA, Kondragunta V, Morgenthaler NG, Struck J, Bergmann A, Mosley TH, Kullo IJ.
    Am J Cardiol; 2009 May 01; 103(9):1255-60. PubMed ID: 19406268
    [Abstract] [Full Text] [Related]

  • 14. Obese Hypertensive Men Have Lower Circulating Proatrial Natriuretic Peptide Concentrations Despite Greater Left Atrial Size.
    Asferg CL, Andersen UB, Linneberg A, Goetze JP, Jeppesen JL.
    Am J Hypertens; 2018 May 07; 31(6):645-650. PubMed ID: 29471357
    [Abstract] [Full Text] [Related]

  • 15. Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity.
    Kistorp C, Bliddal H, Goetze JP, Christensen R, Faber J.
    BMC Obes; 2014 May 07; 1():24. PubMed ID: 26217511
    [Abstract] [Full Text] [Related]

  • 16. Plasma volume contraction reduces atrial natriuretic peptide after four days of hypobaric hypoxia exposure.
    Gatterer H, Rauch S, Regli IB, Woyke S, Schlittler M, Turner R, Strapazzon G, Brugger H, Goetze JP, Feraille E, Siebenmann C.
    Am J Physiol Regul Integr Comp Physiol; 2021 Apr 01; 320(4):R526-R531. PubMed ID: 33533684
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular biomarker midregional proatrial natriuretic peptide during and after preeclamptic pregnancies.
    Sugulle M, Herse F, Hering L, Mockel M, Dechend R, Staff AC.
    Hypertension; 2012 Feb 01; 59(2):395-401. PubMed ID: 22184318
    [Abstract] [Full Text] [Related]

  • 18. Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study.
    Holm H, Nägga K, Nilsson ED, Ricci F, Melander O, Hansson O, Bachus E, Magnusson M, Fedorowski A.
    J Intern Med; 2017 Jul 01; 282(1):94-101. PubMed ID: 28407377
    [Abstract] [Full Text] [Related]

  • 19. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 20. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
    Letzner J, Berger F, Schwabe S, Benzing J, Morgenthaler NG, Bucher HU, Bührer C, Arlettaz R, Wellmann S.
    Neonatology; 2012 Aug 18; 101(2):116-24. PubMed ID: 21952518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.